Clin Endosc.  2015 May;48(3):187-193. 10.5946/ce.2015.48.3.187.

Upper Gastrointestinal Stent Insertion in Malignant and Benign Disorders

• Kang HW
• Kim SG

• KMID: 2148565
• DOI: http://doi.org/10.5946/ce.2015.48.3.187

Abstract

Upper gastrointestinal (GI) stents are increasingly being used to manage upper GI obstructions. Initially developed for palliative treatment of esophageal cancer, upper GI stents now play an emerging role in benign strictures of the upper GI tract. Because recurrent obstruction and stent-related complications are common, new modifications of stents have been implemented. Self-expandable metal stents (SEMS) have replaced older plastic stents. In addition, newly designed SEMS have been developed to prevent complications. This review provides an overview of the various types, indications, methods, complications, and clinical outcomes of upper GI stents in a number of malignant and benign disorders dividing the esophagus and gastroduodenum.

Keyword

Upper gastrointestinal tract; Stents; Obstruction; Malignant; Benign

MeSH Terms

Constriction, Pathologic
Esophageal Neoplasms
Esophagus
Palliative Care
Plastics
Stents*
Upper Gastrointestinal Tract
Plastics

Reference

1. Parrish CR. Nutrition concerns for the patient with gastroparesis. Curr Gastroenterol Rep. 2007; 9:295–302. PMID: 17883976.

2. Didden P, Spaander MC, Bruno MJ, Kuipers EJ. Esophageal stents in malignant and benign disorders. Curr Gastroenterol Rep. 2013; 15:319. PMID: 23463153.

3. Kochar R, Shah N. Enteral stents: from esophagus to colon. Gastrointest Endosc. 2013; 78:913–918. PMID: 24237947.

4. Kim SG, Yang CH. Upper gastrointestinal stent. Clin Endosc. 2012; 45:386–391. PMID: 23251886.

5. Conigliaro R, Battaglia G, Repici A, et al. Polyflex stents for malignant oesophageal and oesophagogastric stricture: a prospective, multicentric study. Eur J Gastroenterol Hepatol. 2007; 19:195–203. PMID: 17301645.

6. Szegedi L, Gál I, Kósa I, Kiss GG. Palliative treatment of esophageal carcinoma with self-expanding plastic stents: a report on 69 cases. Eur J Gastroenterol Hepatol. 2006; 18:1197–1201. PMID: 17033441.

7. Sreedharan A, Harris K, Crellin A, Forman D, Everett SM. Interventions for dysphagia in oesophageal cancer. Cochrane Database Syst Rev. 2009; (4):CD005048. PMID: 19821338.

8. Uitdehaag MJ, Siersema PD, Spaander MC, et al. A new fully covered stent with antimigration properties for the palliation of malignant dysphagia: a prospective cohort study. Gastrointest Endosc. 2010; 71:600–605. PMID: 20003970.

9. Talreja JP, Eloubeidi MA, Sauer BG, et al. Fully covered removable nitinol self-expandable metal stents (SEMS) in malignant strictures of the esophagus: a multicenter analysis. Surg Endosc. 2012; 26:1664–1669. PMID: 22179474.

10. Kim ES, Jeon SW, Park SY, et al. Comparison of double-layered and covered Niti-S stents for palliation of malignant dysphagia. J Gastroenterol Hepatol. 2009; 24:114–119. PMID: 19054264.

11. Hirdes MM, Siersema PD, Vleggaar FP. A new fully covered metal stent for the treatment of benign and malignant dysphagia: a prospective follow-up study. Gastrointest Endosc. 2012; 75:712–718. PMID: 22284093.

12. Shim CS, Jung IS, Bhandari S, et al. Management of malignant strictures of the cervical esophagus with a newly-designed self-expanding metal stent. Endoscopy. 2004; 36:554–557. PMID: 15202054.

13. Shim CS. Esophageal stenting in unusual situations. Endoscopy. 2003; 35:S14–S18. PMID: 12929048.

14. Park JJ, Lee YC, Kim BK, et al. Long-term clinical outcomes of self-expanding metal stents for treatment of malignant gastroesophageal junction obstructions and prognostic factors for stent patency: effects of anticancer treatments. Dig Liver Dis. 2010; 42:436–440. PMID: 19767253.

15. Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol. 2002; 97:72–78. PMID: 11808972.

16. Hirdes MM, Siersema PD, Houben MH, Weusten BL, Vleggaar FP. Stent-in-stent technique for removal of embedded esophageal self-expanding metal stents. Am J Gastroenterol. 2011; 106:286–293. PMID: 20940709.

17. Didden P, Kuipers EJ, Bruno MJ, Spaander MC. Endoscopic removal of a broken self-expandable metal stent using the stent-in-stent technique. Endoscopy. 2012; 44(Suppl 2 UCTN):E232. PMID: 22715009.

18. Park SY, Park CH, Cho SB, et al. The usefulness of clip application in preventing migration of self-expandable metal stent in patients with malignant gastrointestinal obstruction. Korean J Gastroenterol. 2007; 49:4–9. PMID: 18167427.

19. van Boeckel PG, Sijbring A, Vleggaar FP, Siersema PD. Systematic review: temporary stent placement for benign rupture or anastomotic leak of the oesophagus. Aliment Pharmacol Ther. 2011; 33:1292–1301. PMID: 21517921.

20. Bick BL, Song LM, Buttar NS, et al. Stent-associated esophagorespiratory fistulas: incidence and risk factors. Gastrointest Endosc. 2013; 77:181–189. PMID: 23245798.

21. Verschuur EM, Steyerberg EW, Kuipers EJ, Siersema PD. Effect of stent size on complications and recurrent dysphagia in patients with esophageal or gastric cardia cancer. Gastrointest Endosc. 2007; 65:592–601. PMID: 17383456.

22. Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 2001; 54:145–153. PMID: 11474382.

23. Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut. 2003; 52:922–926. PMID: 12801944.

24. Conio M, Repici A, Battaglia G, et al. A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007; 102:2667–2677. PMID: 18042102.

25. Verschuur EM, Repici A, Kuipers EJ, Steyerberg EW, Siersema PD. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am J Gastroenterol. 2008; 103:304–312. PMID: 17900325.

26. van Heel NC, Haringsma J, Boot H, Cats A, Vanhoutvin SA, Kuipers EJ. Comparison of 2 expandable stents for malignant esophageal disease: a randomized controlled trial. Gastrointest Endosc. 2012; 76:52–58. PMID: 22726466.

27. Zhu HD, Guo JH, Mao AW, et al. Conventional stents versus stents loaded with (125)iodine seeds for the treatment of unresectable oesophageal cancer: a multicentre, randomised phase 3 trial. Lancet Oncol. 2014; 15:612–619. PMID: 24742740.

28. Pereira-Lima JC, Ramires RP, Zamin I Jr, Cassal AP, Marroni CA, Mattos AA. Endoscopic dilation of benign esophageal strictures: report on 1043 procedures. Am J Gastroenterol. 1999; 94:1497–1501. PMID: 10364013.

29. Raymondi R, Pereira-Lima JC, Valves A, et al. Endoscopic dilation of benign esophageal strictures without fluoroscopy: experience of 2750 procedures. Hepatogastroenterology. 2008; 55:1342–1348. PMID: 18795685.

30. Thomas T, Abrams KR, Subramanian V, Mannath J, Ragunath K. Esophageal stents for benign refractory strictures: a meta-analysis. Endoscopy. 2011; 43:386–393. PMID: 21437850.

31. Dua KS, Vleggaar FP, Santharam R, Siersema PD. Removable self-expanding plastic esophageal stent as a continuous, non-permanent dilator in treating refractory benign esophageal strictures: a prospective two-center study. Am J Gastroenterol. 2008; 103:2988–2994. PMID: 18786110.

32. Holm AN, de la Mora Levy JG, Gostout CJ, Topazian MD, Baron TH. Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc. 2008; 67:20–25. PMID: 17945227.

33. Karbowski M, Schembre D, Kozarek R, Ayub K, Low D. Polyflex self-expanding, removable plastic stents: assessment of treatment efficacy and safety in a variety of benign and malignant conditions of the esophagus. Surg Endosc. 2008; 22:1326–1333. PMID: 18027044.

34. Kitta Y, Obata JE, Takano H, et al. Echolucent carotid plaques predict in-stent restenosis after bare metal stenting in native coronary arteries. Atherosclerosis. 2008; 197:177–182. PMID: 17466305.

35. Hirdes MM, Siersema PD, van Boeckel PG, Vleggaar FP. Single and sequential biodegradable stent placement for refractory benign esophageal strictures: a prospective follow-up study. Endoscopy. 2012; 44:649–654. PMID: 22723182.

36. Repici A, Conio M, De Angelis C, et al. Temporary placement of an expandable polyester silicone-covered stent for treatment of refractory benign esophageal strictures. Gastrointest Endosc. 2004; 60:513–519. PMID: 15472671.

37. Brinster CJ, Singhal S, Lee L, Marshall MB, Kaiser LR, Kucharczuk JC. Evolving options in the management of esophageal perforation. Ann Thorac Surg. 2004; 77:1475–1483. PMID: 15063302.

38. Attar S, Hankins JR, Suter CM, Coughlin TR, Sequeira A, McLaughlin JS. Esophageal perforation: a therapeutic challenge. Ann Thorac Surg. 1990; 50:45–49. PMID: 2369229.

39. Dechene A, El Fouly AH, Bechmann LP, et al. Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents. Digestion. 2012; 85:185–191. PMID: 22269340.

40. Hubmann R, Bodlaj G, Czompo M, et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy. 2006; 38:896–901. PMID: 16981106.

41. Wright G, Lewis H, Hogan B, Burroughs A, Patch D, O'Beirne J. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc. 2010; 71:71–78. PMID: 19879564.

42. Zehetner J, Shamiyeh A, Wayand W, Hubmann R. Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc. 2008; 22:2149–2152. PMID: 18622540.

43. Shone DN, Nikoomanesh P, Smith-Meek MM, Bender JS. Malignancy is the most common cause of gastric outlet obstruction in the era of H2 blockers. Am J Gastroenterol. 1995; 90:1769–1770. PMID: 7572891.

44. Jeurnink SM, Steyerberg EW, van Hooft JE, et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc. 2010; 71:490–499. PMID: 20003966.

45. van Heek NT, van Geenen RC, Busch OR, Gouma DJ. Palliative treatment in "peri"-pancreatic carcinoma: stenting or surgical therapy? Acta Gastroenterol Belg. 2002; 65:171–175. PMID: 12420610.

46. Mendelsohn RB, Gerdes H, Markowitz AJ, DiMaio CJ, Schattner MA. Carcinomatosis is not a contraindication to enteral stenting in selected patients with malignant gastric outlet obstruction. Gastrointest Endosc. 2011; 73:1135–1140. PMID: 21470604.

47. Dormann AJ, Deppe H, Wigginghaus B. Self-expanding metallic stents for continuous dilatation of benign stenoses in gastrointestinal tract - first results of long-term follow-up in interim stent application in pyloric and colonic obstructions. Z Gastroenterol. 2001; 39:957–960. PMID: 11778154.

48. Binkert CA, Jost R, Steiner A, Zollikofer CL. Benign and malignant stenoses of the stomach and duodenum: treatment with self-expanding metallic endoprostheses. Radiology. 1996; 199:335–338. PMID: 8668774.

49. Pinto Pabón IT, Díaz LP, Ruiz De Adana JC, López Herrero J. Gastric and duodenal stents: follow-up and complications. Cardiovasc Intervent Radiol. 2001; 24:147–153. PMID: 11443401.

50. Baron TH, Schöfl R, Puespoek A, Sakai Y. Expandable metal stent placement for gastric outlet obstruction. Endoscopy. 2001; 33:623–628. PMID: 11476083.

51. Baron TH. Minimizing endoscopic complications: endoluminal stents. Gastrointest Endosc Clin N Am. 2007; 17:83–104. PMID: 17397778.

52. Hamada T, Nakai Y, Isayama H, et al. Duodenal metal stent placement is a risk factor for biliary metal stent dysfunction: an analysis using a time-dependent covariate. Surg Endosc. 2013; 27:1243–1248. PMID: 23073685.

53. Sasaki T, Isayama H, Nakai Y, et al. Clinical outcomes of secondary gastroduodenal self-expandable metallic stent placement by stent-in-stent technique for malignant gastric outlet obstruction. Dig Endosc. 2015; 27:37–43. PMID: 24995858.

54. van Hooft JE, Uitdehaag MJ, Bruno MJ, et al. Efficacy and safety of the new WallFlex enteral stent in palliative treatment of malignant gastric outlet obstruction (DUOFLEX study): a prospective multicenter study. Gastrointest Endosc. 2009; 69:1059–1066. PMID: 19152912.

55. Jeurnink SM, van Eijck CH, Steyerberg EW, Kuipers EJ, Siersema PD. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol. 2007; 7:18. PMID: 17559659.

56. Masci E, Viale E, Mangiavillano B, et al. Enteral self-expandable metal stent for malignant luminal obstruction of the upper and lower gastrointestinal tract: a prospective multicentric study. J Clin Gastroenterol. 2008; 42:389–394. PMID: 18277900.

57. Piesman M, Kozarek RA, Brandabur JJ, et al. Improved oral intake after palliative duodenal stenting for malignant obstruction: a prospective multicenter clinical trial. Am J Gastroenterol. 2009; 104:2404–2411. PMID: 19707192.

58. Khashab M, Alawad AS, Shin EJ, et al. Enteral stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction. Surg Endosc. 2013; 27:2068–2075. PMID: 23299137.

59. Tringali A, Didden P, Repici A, et al. Endoscopic treatment of malignant gastric and duodenal strictures: a prospective, multicenter study. Gastrointest Endosc. 2014; 79:66–75. PMID: 23932009.

60. Song GA, Kang DH, Kim TO, et al. Endoscopic stenting in patients with recurrent malignant obstruction after gastric surgery: uncovered versus simultaneously deployed uncovered and covered (double) self-expandable metal stents. Gastrointest Endosc. 2007; 65:782–787. PMID: 17324410.

61. Kim TO, Kang DH, Kim GH, et al. Self-expandable metallic stents for palliation of patients with malignant gastric outlet obstruction caused by stomach cancer. World J Gastroenterol. 2007; 13:916–920. PMID: 17352023.

62. Espinel J, Sanz O, Vivas S, et al. Malignant gastrointestinal obstruction: endoscopic stenting versus surgical palliation. Surg Endosc. 2006; 20:1083–1087. PMID: 16703436.

63. Maire F, Hammel P, Ponsot P, et al. Long-term outcome of biliary and duodenal stents in palliative treatment of patients with unresectable adenocarcinoma of the head of pancreas. Am J Gastroenterol. 2006; 101:735–742. PMID: 16635221.

64. Maetani I, Akatsuka S, Ikeda M, et al. Self-expandable metallic stent placement for palliation in gastric outlet obstructions caused by gastric cancer: a comparison with surgical gastrojejunostomy. J Gastroenterol. 2005; 40:932–937. PMID: 16261429.

65. Mehta S, Hindmarsh A, Cheong E, et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg Endosc. 2006; 20:239–242. PMID: 16362479.

66. Kim JH, Song HY, Shin JH, et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc. 2007; 66:256–264. PMID: 17643698.

67. Shaw JM, Bornman PC, Krige JE, Stupart DA, Panieri E. Self-expanding metal stents as an alternative to surgical bypass for malignant gastric outlet obstruction. Br J Surg. 2010; 97:872–876. PMID: 20309895.

68. van den Berg MW, Haijtink S, Fockens P, et al. First data on the Evolution duodenal stent for palliation of malignant gastric outlet obstruction (DUOLUTION study): a prospective multicenter study. Endoscopy. 2013; 45:174–181. PMID: 23348890.

69. No JH, Kim SW, Lim CH, et al. Long-term outcome of palliative therapy for gastric outlet obstruction caused by unresectable gastric cancer in patients with good performance status: endoscopic stenting versus surgery. Gastrointest Endosc. 2013; 78:55–62. PMID: 23522025.

70. Fiori E, Lamazza A, Demasi E, Decesare A, Schillaci A, Sterpetti AV. Endoscopic stenting for gastric outlet obstruction in patients with unresectable antro pyloric cancer. Systematic review of the literature and final results of a prospective study. The point of view of a surgical group. Am J Surg. 2013; 206:210–217. PMID: 23735668.

71. Nagaraja V, Eslick GD, Cox MR. Endoscopic stenting versus operative gastrojejunostomy for malignant gastric outlet obstruction-a systematic review and meta-analysis of randomized and non-randomized trials. J Gastrointest Oncol. 2014; 5:92–98. PMID: 24772336.

72. Cho YK, Kim SW, Hur WH, et al. Clinical outcomes of self-expandable metal stent and prognostic factors for stent patency in gastric outlet obstruction caused by gastric cancer. Dig Dis Sci. 2010; 55:668–674. PMID: 19333756.

73. Jeurnink SM, Steyerberg EW, Hof G, van Eijck CH, Kuipers EJ, Siersema PD. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol. 2007; 96:389–396. PMID: 17474082.

74. Roy A, Kim M, Christein J, Varadarajulu S. Stenting versus gastrojejunostomy for management of malignant gastric outlet obstruction: comparison of clinical outcomes and costs. Surg Endosc. 2012; 26:3114–3119. PMID: 22549377.

75. Kim JH, Yoo BM, Lee KJ, et al. Self-expanding coil stent with a long delivery system for palliation of unresectable malignant gastric outlet obstruction: a prospective study. Endoscopy. 2001; 33:838–842. PMID: 11571678.

76. Shike M, Latkany L, Gerdes H, Bloch AS. Direct percutaneous endoscopic jejunostomies for enteral feeding. Gastrointest Endosc. 1996; 44:536–540. PMID: 8934158.

77. Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N Engl J Med. 2001; 344:1681–1687. PMID: 11386268.

78. Choi WJ, Park JJ, Park J, et al. Effects of the temporary placement of a self-expandable metallic stent in benign pyloric stenosis. Gut Liver. 2013; 7:417–422. PMID: 23898381.